⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL451396 | 0.75 | — | — | |
| SCHEMBL151822 | 0.73 | LOXL2 (0.68) | — | |
| SCHEMBL721736 | 0.73 | CYP17A1 (0.61) | — | |
| Ammonia Solution, Strong SCHEMBL9306930 | 0.71 | LOXL2 (0.65) | — | |
| Water SCHEMBL31124596 | 0.71 | LOXL2 (0.65) | — | |
| Water SCHEMBL31124597 | 0.71 | LOXL2 (0.65) | — | |
| SCHEMBL13873567 | 0.71 | CYP17A1 (0.65) | — | |
| Hydrochloric Acid SCHEMBL11103093 | 0.69 | — | — | |
| SCHEMBL42462 | 0.69 | — | — | |
| SCHEMBL726645 | 0.69 | HRH1 (0.73) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2018364-B1 | THERAPEUTIC FLUOROETHYL UREAS | ALLERGAN INC (US) | 2013-08-21 | — | — | EP | disclosed |
| US-20130143928-A1 | BIS-PYRINIDIUM COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2013-06-06 | — | — | US | disclosed |
| US-7709507-B2 | Therapeutic fluoroethyl ureas | ALLERGAN, INC. (US) | 2010-05-04 | — | — | US | disclosed |
| US-20100016367-A1 | BIS-PYRINIDIUM COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2010-01-21 | — | — | US | disclosed |
| EP-2018364-A1 | THERAPEUTIC FLUOROETHYL UREAS | Allergan, Inc. (US) | 2009-01-28 | — | — | EP | disclosed |
| EP-2016069-A1 | BIS-PYRIDINIUM COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2009-01-21 | — | — | EP | disclosed |
| US-20080200679-A1 | Alpha-HYDROXY, alpha-SUBSTITUTED METHYLENEBISPHOSPHONATES AND PHOSPHONOACETATES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2008-08-21 | — | — | US | disclosed |
| WO-2007137029-A1 | THERAPEUTIC FLUOROETHYL UREAS | ALLERGAN, INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070270498-A1 | THERAPEUTIC FLUOROETHYL UREAS | ALLERGAN, INC. | 2007-11-22 | — | — | US | disclosed |
| WO-2007128059-A1 | BIS-PYRIDINIUM COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2007-11-15 | — | — | WO | disclosed |
| EP-0738714-A2 | Process for preparing new fibrinogen receptor antagonists | MERCK & CO. INC. (US) | 1996-10-23 | — | — | EP | disclosed |
| CN-1076441-A | The method for preparing fibrinogen deceptor antagonists | MERCK & CO INC (US) | 1993-09-22 | — | — | CN | disclosed |
| WO-1993016995-A1 | PROCESS FOR PREPARING FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1993-09-02 | — | — | WO | disclosed |
| EP-0558139-A1 | Process for preparing fibrinogen receptor antagonists | MERCK & CO. INC. (US) | 1993-09-01 | — | — | EP | disclosed |
| US-5206373-A | Process for preparing fibrinogen receptor antagonists | MERCK & CO., INC. (US) | 1993-04-27 | — | — | US | disclosed |
| EP-0428849-A2 | Retroviral protease inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-05-29 | — | — | EP | disclosed |
| US-4499287-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1985-02-12 | — | — | US | disclosed |
| US-4456761-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1984-06-26 | — | — | US | disclosed |
| US-4356182-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-10-26 | — | — | US | disclosed |
| US-4291040-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1981-09-22 | — | — | US | disclosed |